GlaxoSmithkline Consumer Healthcare Quarter results- Q3 2013

Press Release
Gurgaon, NCR India, November 6, 2013


Financial Highlights:

  • Sales up by 17%

  • Net Profits up by 14%

  • Performance driven by market penetration, greater access to products and cost efficiency

Overview________________________________________________________________________________

GlaxoSmithKline Consumer Healthcare Limited (GSKCH) today declared its financial results for the quarter ended September 30, 2013. Net sales at Rs 972 crores recorded a growth of 17 % over 2012 with PBT at Rs. 224 crores growing by 18 % for the same period and PAT at Rs 147 crores growing by 14 %.

Commenting on the Company’s performance, Mr. Zubair Ahmed, MD, GSK Consumer Healthcare India, said, “We are delighted to deliver yet another quarter of profitable growth against the backdrop of slow down being seen across most FMCG categories. We continue to strengthen our performance through innovation, high science and strong consumer connect. Our focus on greater penetration across categories, offering high science based products at competitive price points has helped in the growth of our brands. As a company that is committed to help people to 'Do More, Feel Better, Live Longer', our endeavour is to continuously provide value based products to our consumers through our diverse portfolio of brands across all markets.”

India Performance
Another quarter of strong double digit profitable growth was driven by superior Sales performance and a strong cost management programme.

GSK Consumer Healthcare is committed to top line growth and has been exceeding expectations over the last quarters by remarkably maintaining its performance.

Strategic Priority
Connect with and develop new markets.
Deliver products based on high science to provide value.
Provide accessible nutrition through low unit price packs.
Enhance availability with greater focus on tier 2 cities and rural
Simplify Operating model.

Highlights Health Food Drinks
The GSK health drink portfolio continues to be a market leader with 58.6% (Value sales) and 65.2% (Volume share) – (MAT Sept, 2013). Its closest competitor have market share of 15.0% (Value Market Share) and 16.8% (Volume Market Share) – (MAT Sept, 13).

Strong growth of Horlicks in India – up by 16% in Q3.
Sales of Boost energy drink - up by 19% in Q3.
Launch of Boost Choco Nut – in July, 2013.

About GlaxoSmithKline Consumer Healthcare Ltd
GSK Consumer Healthcare is a subsidiary of GlaxoSmithKline plc. of U.K, a global science based healthcare company. GSK Consumer Healthcare has continually benefited from the technical and marketing inputs that have been available as a consequence of this association. GSKCH is the largest player in the health food drinks industry. The Company with its manufacturing plants located in Nabha, Rajahmundry and Sonepat has a total workforce of about 3475 people.

GSK Consumer Healthcare has a strong marketing and distribution network in India comprising over 700 distributors and a direct coverage of over 8 lakh retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 100 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent names such as Eno, Crocin and Iodex as well as products from the global portfolio like and Sensodyne.

Media Contacts ______________________________________________________
Genesis Burson Marsteller

Divya Bakhshi divya.bakhshi@bm.com+91 9899888643

GlaxoSmithKline Consumer Healthcare

Deepa Dey deepa.d.dey@gsk.com